UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
Amgen Korea has received an expanded indication for Blincyto, a treatment f...
by Lee Han-soo
|
2020-09-04 18:04
라인
Despite slowing down virus cases, tight restrictions continue in Seoul
Korea reported new Covid-19 cases of below 200 for two consecutive days on ...
by Lee Han-soo
|
2020-09-04 14:16
라인
Iraq approves Hutox as 1st BTX product
Huons said that Iraqi health authorities have approved Hutox, its botulinum...
by Lee Han-soo
|
2020-09-04 14:16
라인
Pharmaceuticals, CROs have hard time doing clinical trials amid prolonged pandemic
Amid the protracted Covid-19 pandemic, pharmaceutical and contract research...
by Lee Han-soo
|
2020-09-03 19:24
라인
Daewoong to expand indication of Nabota in US
Daewoong Pharmaceutical said it would enter the treatment market for botuli...
by Lee Han-soo
|
2020-09-03 12:13
라인
New virus cases fall below 200 but critical patients surge
Korea's new Covid-19 cases fell to the lowest level in more than two we...
by Lee Han-soo
|
2020-09-03 11:27
라인
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
Researchers at Seoul National University Bundang Hospital (SNUBH) have deve...
by Lee Han-soo
|
2020-09-02 15:20
라인
FDA grants priority review to Hanmi’s Oraxol
Hanmi said the U.S. Food and Drug Administration has approved the new drug ...
by Lee Han-soo
|
2020-09-02 13:06
라인
New virus cases slow down – for now
Korea reported new Covid-19 cases of below 300 for the fourth day on Wednes...
by Lee Han-soo
|
2020-09-02 11:06
라인
State researchers develop more accurate gene scissor tech
The Korea Research Institute of Bioscience & Biotechnology (KRIBB) said its...
by Lee Han-soo
|
2020-09-01 18:01
라인
'Malaria treatment plus nanotech increases radiation cancer treatment’s effect'
Researchers at the National Cancer Center have proved that a porous nanobal...
by Lee Han-soo
|
2020-09-01 15:40
라인
LSK Global PS to conduct P3 trial of Sinovac's Covid-19 vaccine candidate
LSK Global Pharma Services said that it would conduct the phase 3 clinical ...
by Lee Han-soo
|
2020-09-01 12:17
라인
Accumulated caseload tops 20,000 amid sharp rise of seriously ill
Korea’s new Covid-19 cases stayed below 300 for two consecutive days on Mon...
by Lee Han-soo
|
2020-09-01 11:25
라인
GC MS to increase export of Covid-19 diagnostic kit
GC MS said that it has obtained an export approval for GENEDIA W COVID-19 A...
by Lee Han-soo
|
2020-08-31 16:29
라인
Method developed to diagnose Alzheimer's with 1 body fluid drop
A Korea University-Kyung Hee University research team has developed a highl...
by Lee Han-soo
|
2020-08-31 14:02
라인
Collaboration: One way to simplify complexities in drug development
The rapidly expanding global healthcare industry has created intensifying d...
by Lee Han-soo
|
2020-08-31 13:52
라인
As cumulative caseload nears 20,000, ‘no-move’ week in capital area
Korea's new virus cases stayed below 300 on Sunday, but massive outbrea...
by Lee Han-soo
|
2020-08-31 12:58
라인
Hanmi terminates global P2 trial for poziotinib
Hanmi Pharmaceutical has terminated its global phase 2 clinical trial for p...
by Lee Han-soo
|
2020-08-21 15:56
라인
New virus cases top 300; tighter restrictions eyed in greater Seoul
Korea's daily Covid-19 cases surpassed 300 as community outbreaks conti...
by Lee Han-soo
|
2020-08-21 14:29
라인
Samsung Bioepis wins European nod for Avastin biosimilar
Samsung Bioepis said that it has obtained a sales approval for Aybintio, a ...
by Lee Han-soo
|
2020-08-21 11:32
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top